Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: ESSENTIAL ACCESS HEALTH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2013-07-16 to 2022-03-31
Current total value of award: $1420018.61
Description: A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE